 |
Name: | ERLOTINIB HYDROCHLORIDE |
| Synonyms: | N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; Tarceva | |
| CAS: | 183319-69-9 | |
| Molecular Formula: | C22H23N3O4.HCl | |
| Molecular Weight: | 429.90[g/mol] | |
| Specifications: | BP, USP, enterprise stardard | |
| MSDS: | ERLOTINIB HYDROCHLORIDE.PDF | |
| Capacity: | In custom-tailor, stock, | |
| Period of validity: | 2 years-- (Kept airtightly in a light-proof, dry and cool place) | |
| Package: | custom-tailor, 25kg/drum | |
| Free encyclopedia | Erlotinib hydrochloride (Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche. | |
| service@lyg-china.com | Back | |
|
|
About us | Product list | Contact us |
Link |Copyright © 2010 | All rights Reserved|
SU-ICP-No.08113839|Address: 6F Nanguang Building, 43 Hailian East Road, Lianyungang, China|